BLISSGVS

BLISS GVS PHARMA

Small Cap BSE: 506197 NSE: BLISSGVS
₹76.6
-0.2 (-0.26%)
As on 13 August, 2022 | 06:46

Bliss Gvs Pharma Share Price

Bliss Gvs Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Bliss Gvs Pharma Share Returns

  • Over 1 Month 1.39%
  • Over 3 Month 11.01%
  • Over 6 Month -17%
  • Over 1 Year -32.76%

Bliss Gvs Pharma Key Statistics

P/E Ratio 48.2
PEG Ratio -0.6
Market Cap Cr 795
Price to Book Ratio 0.9
EPS 8.7
Dividend 1.3
Relative Strength Index 46.33
Money Flow Index 46.45
MACD Signal 0.48
Average True Range 2.38

Bliss Gvs Pharma Investment Rating

  • Master Rating:
  • Bliss Gvs Pharma has an operating revenue of Rs. 767.97 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 7% is okay, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Bliss GVS Pharma Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 147
  • 138
  • 191
  • 174
  • 133
  • 105
  • Operating Expenses Qtr Cr
  • 128
  • 129
  • 159
  • 142
  • 107
  • 90
  • Operating Profit Qtr Cr
  • 19
  • 9
  • 32
  • 33
  • 26
  • 15
  • Depreciation Qtr Cr
  • 4
  • 3
  • 4
  • 3
  • 3
  • 3
  • Interest Qtr Cr
  • 2
  • 2
  • 1
  • 1
  • 1
  • 2
  • Tax Qtr Cr
  • 7
  • 7
  • 9
  • 10
  • 7
  • 5
  • Net Profit Qtr Cr
  • 25
  • 9
  • 27
  • 25
  • 22
  • 9

Bliss Gvs Pharma Technicals

EMA & SMA

Current Price
76.65
-0.15 (-0.2%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 77.51
  • 50 Day
  • 77.2
  • 100 Day
  • 79.35
  • 200 Day
  • 85.97
  • 20 Day
  • 78.42
  • 50 Day
  • 76.87
  • 100 Day
  • 76.92
  • 200 Day
  • 85.92

Bliss Gvs Pharma Resistance and Support

PIVOT
₹77.04
Resistance
  • First Resistance
  • 77.57
  • Second Resistance
  • 78.34
  • Third Resistance
  • 78.87
Support
  • First Resistance
  • 76.27
  • Second Resistance
  • 75.74
  • Third Resistance
  • 74.97
  • RSI
  • 46.33
  • MFI
  • 46.45
  • MACD Single Line
  • 0.48
  • MACD
  • 0.21

Bliss Gvs Pharma Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 69,367
  • 4,590,014
  • 66.17
  • Week
  • 73,723
  • 5,095,716
  • 69.12
  • 1 Month
  • 160,252
  • 7,323,521
  • 45.7
  • 6 Month
  • 278,497
  • 12,841,493
  • 46.11

Bliss Gvs Pharma Result Highlights

Bliss GVS Pharma Synopsis

NSE-Medical-Generic Drugs

Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 636.36 Cr. and Equity Capital is Rs. 10.37 Cr. for the Year ended 31/03/2022. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.
  • Market Cap
  • 796
  • Sales
  • 651
  • Shares in Float
  • 6.75
  • No of funds
  • 27
  • Yield
  • 0.65
  • Book Value
  • 0.93
  • U/D Vol ratio
  • 1.6
  • LTDebt / Equity
  • 3
  • Alpha
  • -0.15
  • Beta
  • 0.84

Bliss GVS Pharma

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 34.51%
  • 33.14%
  • 33.14%
  • Mutual Funds
  • Insurance Companies
  • 6.65%
  • 6.66%
  • 6.66%
  • Foreign Portfolio Investors
  • 17.17%
  • 17.33%
  • 19.59%
  • Financial Institutions/ Banks
  • Individual Investors
  • 30.15%
  • 30.36%
  • 28.26%
  • Others
  • 11.52%
  • 12.51%
  • 12.35%

Bliss GVS Pharma Management

  • Name
  • Designation
  • Mr. S R Vaidya
  • Chairman & Ind.Director
  • Mr. Gagan Harsh Sharma
  • Managing Director
  • Dr. Vibha Gagan Sharma
  • Whole Time Director
  • Mrs. Shruti Vishal Rao
  • Whole Time Director
  • Mr. Santosh Parab
  • Independent Director
  • Mrs. Shilpa Bhatia
  • Independent Director

Bliss Gvs Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bliss Gvs Pharma Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-04-30
  • Audited Results & Final Dividend
  • 2022-01-29
  • Quarterly Results
  • 2021-10-30
  • Quarterly Results
  • 2021-07-31
  • Quarterly Results
  • 2021-05-11
  • Audited Results & Final Dividend

Bliss GVS Pharma MF Shareholding

  • Name
  • Amount(cr)

Bliss GVS Pharma FAQs

What is Share Price of Bliss GVS Pharma ?

Bliss GVS Pharma share price is ₹76 As on 13 August, 2022 | 06:32

What is the Market Cap of Bliss GVS Pharma ?

The Market Cap of Bliss GVS Pharma is ₹795.2 Cr As on 13 August, 2022 | 06:32

What is the P/E ratio of Bliss GVS Pharma ?

The P/E ratio of Bliss GVS Pharma is 48.2 As on 13 August, 2022 | 06:32

What is the PB ratio of Bliss GVS Pharma ?

The PB ratio of Bliss GVS Pharma is 0.9 As on 13 August, 2022 | 06:32

Q1FY23